Advanced Biomed Statistics
Total Valuation
Advanced Biomed has a market cap or net worth of $9.76 million. The enterprise value is $7.90 million.
Important Dates
The last earnings date was Monday, October 27, 2025, before market open.
| Earnings Date | Oct 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Advanced Biomed has 21.64 million shares outstanding. The number of shares has increased by 2.63% in one year.
| Current Share Class | 21.64M |
| Shares Outstanding | 21.64M |
| Shares Change (YoY) | +2.63% |
| Shares Change (QoQ) | +5.64% |
| Owned by Insiders (%) | 80.97% |
| Owned by Institutions (%) | 0.61% |
| Float | 4.12M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.74 |
| P/TBV Ratio | 2.74 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.09, with a Debt / Equity ratio of 0.36.
| Current Ratio | 2.09 |
| Quick Ratio | 1.09 |
| Debt / Equity | 0.36 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -126.79% and return on invested capital (ROIC) is -51.61%.
| Return on Equity (ROE) | -126.79% |
| Return on Assets (ROA) | -34.42% |
| Return on Invested Capital (ROIC) | -51.61% |
| Return on Capital Employed (ROCE) | -83.38% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$105,128 |
| Employee Count | 31 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.46 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 47.34 |
| Average Volume (20 Days) | 943,778 |
Short Selling Information
The latest short interest is 119,583, so 0.55% of the outstanding shares have been sold short.
| Short Interest | 119,583 |
| Short Previous Month | 25,320 |
| Short % of Shares Out | 0.55% |
| Short % of Float | 2.90% |
| Short Ratio (days to cover) | 0.05 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -3.02M |
| Pretax Income | -3.26M |
| Net Income | -3.26M |
| EBITDA | -2.68M |
| EBIT | -3.02M |
| Earnings Per Share (EPS) | -$0.16 |
Full Income StatementBalance Sheet
The company has $2.90 million in cash and $1.26 million in debt, giving a net cash position of $1.64 million or $0.08 per share.
| Cash & Cash Equivalents | 2.90M |
| Total Debt | 1.26M |
| Net Cash | 1.64M |
| Net Cash Per Share | $0.08 |
| Equity (Book Value) | 3.48M |
| Book Value Per Share | 0.16 |
| Working Capital | 3.14M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$5.83 million and capital expenditures -$31,650, giving a free cash flow of -$5.86 million.
| Operating Cash Flow | -5.83M |
| Capital Expenditures | -31,650 |
| Free Cash Flow | -5.86M |
| FCF Per Share | -$0.27 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
